In 2021, BCBS Michigan spent $8 million on GLP-1 medications
Key pharmaceutical players, including Novo Nordisk and Eli Lilly, are conducting innovative clinical trials, while strategic collaborations with biotech startups accelerate R&D
These natural approaches may provide metabolic benefits, but their effects are generally much smaller in magnitude compared to prescription GLP-1 receptor agonists like semaglutide
Contraindications Not recommended for use by pregnant women, breastfeeding mothers, or people allergic to any of the ingredients of the product
10.1159/000446951 [DOI] [PubMed] [Google Scholar] Yusta, B
Disclaimer: Retatrutide is currently an investigational medication being studied in clinical trials and has not been approved by the FDA